抗生素时机对英国地区综合医院革兰阴性菌菌血症死亡率的影响:每次都正确的重要性
该研究对789例大肠埃希菌、克雷伯菌属和铜绿假单胞菌菌血症患者进行多变量生存分析,评估血培养时、内科医生接诊时及血培养后24和48小时四个连续时间点有效抗生素对30天全因死亡率和住院时间的影响。结果显示,血培养时经验性抗生素无效与30天死亡率升高独立相关(HR=1.68),若接诊医生继续使用无效药物或血培养后24小时仍无效,死亡风险进一步增加。有效初始抗生素未显著缩短住院时间(-2.98天,P=0.058)。
要点
- 血培养时经验性抗生素无效与30天死亡率升高独立相关(HR=1.68,95%CI 1.19-2.38,P=0.004)。
- 接诊医生继续无效治疗或24小时仍无效时死亡风险更高(HR分别为2.73和1.83)。
- 治疗不当主因为体外耐药(48.6%)、感染源误诊(22.7%)和未遵循医院指南(15.7%)。
核心结论
- 连续的处方决策影响革兰阴性菌菌血症患者的死亡率。
研究设计与样本
- 对789例大肠埃希菌、克雷伯菌属和铜绿假单胞菌菌血症患者进行多变量生存分析,回顾血培养时、接诊时及血培养后24和48小时的抗生素选择。
主要发现
- 血培养时经验性抗生素无效者30天死亡风险更高(HR=1.68,95%CI 1.19-2.38,P=0.004)。
- 接诊医生继续无效治疗者死亡风险更高(HR=2.73,95%CI 1.58-4.73,P<0.001)。
- 血培养后24小时仍无效者死亡风险更高(HR=1.83,95%CI 1.05-3.20,P=0.033)。
- 医院获得性感染、高接种量感染及C反应蛋白、乳酸和Charlson合并症指数升高为死亡的独立预测因素。
- 有效初始抗生素未显著缩短住院时间(-2.98天,95%CI -6.08-0.11,P=0.058)。
关键数值与推荐
- 治疗不当的主要原因包括体外抗菌药物耐药(48.6%)、初始感染源误诊(22.7%)和未遵循医院指南(15.7%)。
临床怎么用
- 应确保血培养时经验性抗生素覆盖可能病原体,并在接诊和24小时复查时及时调整无效方案。
- 需关注医院获得性感染、高接种量感染及炎症标志物和合并症指数升高的高危患者。
- 应针对耐药、感染源误诊和指南依从性开展质量改进。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: There is limited evidence that empirical antimicrobials affect patient-oriented outcomes in Gram-negative bacteraemia. We aimed to establish the impact of effective antibiotics at four consecutive timepoints on 30 day all-cause mortality and length of stay in hospital. METHODS: We performed a multivariable survival analysis on 789 patients with Escherichia coli, Klebsiella spp. and Pseudomonas aeruginosa bacteraemias. Antibiotic choices at the time of the blood culture (BC), the time of medical clerking and 24 and 48 h post-BC were reviewed. RESULTS: Patients that received ineffective empirical antibiotics at the time of the BC had higher risk of mortality before 30 days (HR = 1.68, 95% CI = 1.19-2.38, P = 0.004). Mortality was higher if an ineffective antimicrobial was continued by the clerking doctor (HR = 2.73, 95% CI = 1.58-4.73, P < 0.001) or at 24 h from the BC (HR = 1.83, 95% CI = 1.05-3.20, P = 0.033) when compared with patients who received effective therapy throughout. Hospital-onset infections, 'high inoculum' infections and elevated C-reactive protein, lactate and Charlson comorbidity index were independent predictors of mortality. Effective initial antibiotics did not statistically significantly reduce length of stay in hospital (-2.98 days, 95% CI = -6.08-0.11, P = 0.058). The primary reasons for incorrect treatment were in vitro antimicrobial resistance (48.6%), initial misdiagnosis of infection source (22.7%) and non-adherence to hospital guidelines (15.7%). CONCLUSIONS: Consecutive prescribing decisions affect mortality from Gram-negative bacteraemia.
引用
- Baltas I, Stockdale T, Tausan M, et al. Impact of antibiotic timing on mortality from Gram-negative bacteraemia in an English district general hospital: the importance of getting it right every time. J Antimicrob Chemother. 2021. PMID: 33219669. doi:10.1093/jac/dkaa478
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。